BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23875912)

  • 1. DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype.
    De Vriendt V; De Roock W; Di Narzo AF; Tian S; Biesmans B; Jacobs B; Budinska E; Sagaert X; Rossi S; D'Ario G; Delorenzi M; Simon I; Vecchione L; Tejpar S
    Biomarkers; 2013 Sep; 18(6):516-24. PubMed ID: 23875912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
    Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
    Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma.
    Lee EK; Chung KW; Yang SK; Park MJ; Min HS; Kim SW; Kang HS
    Anticancer Res; 2013 Nov; 33(11):4833-9. PubMed ID: 24222120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.
    Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M
    Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of
    Varela T; Laizé V; Conceição N; Caldeira P; Marreiros A; Guerreiro H; Cancela ML
    Biomark Med; 2020 Jun; 14(8):639-650. PubMed ID: 32613839
    [No Abstract]   [Full Text] [Related]  

  • 6. Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.
    Ito T; Young MJ; Li R; Jain S; Wernitznig A; Krill-Burger JM; Lemke CT; Monducci D; Rodriguez DJ; Chang L; Dutta S; Pal D; Paolella BR; Rothberg MV; Root DE; Johannessen CM; Parida L; Getz G; Vazquez F; Doench JG; Zamanighomi M; Sellers WR
    Nat Genet; 2021 Dec; 53(12):1664-1672. PubMed ID: 34857952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
    Cagnol S; Rivard N
    Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microRNA-429/DUSP4 axis regulates the sensitivity of colorectal cancer cells to nintedanib.
    Cheng G; Li Y; Liu Z; Song X
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33495832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Specificity Phosphatases in Immunity and Infection: An Update.
    Lang R; Raffi FAM
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling.
    Britson JS; Barton F; Balko JM; Black EP
    Biochem Biophys Res Commun; 2009 Dec; 390(3):849-54. PubMed ID: 19836351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer.
    Boulding T; Wu F; McCuaig R; Dunn J; Sutton CR; Hardy K; Tu W; Bullman A; Yip D; Dahlstrom JE; Rao S
    PLoS One; 2016; 11(2):e0148065. PubMed ID: 26859151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
    Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
    Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent manner.
    Yin R; Eger G; Sarri N; Rorsman C; Heldin CH; Lennartsson J
    Biochem Biophys Res Commun; 2019 Nov; 519(3):469-474. PubMed ID: 31526568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abundance of Dual Specificity Phosphatase (DUSP) 1 and DUSP6 mRNA Is Regulated by Hippo Signaling in Bovine Pre-ovulatory Granulosa Cells.
    Relav L; Dos Santos EC; Zamberlam G; Price CA
    Reprod Sci; 2023 Jun; 30(6):1782-1788. PubMed ID: 36474130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer.
    Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Okugawa Y; Shimura T; Hiro J; Uchida K; Mohri Y; Kusunoki M
    Med Oncol; 2013; 30(3):620. PubMed ID: 23749251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells.
    Kamada H; Yasuhira S; Shibazaki M; Amano H; Maesawa C
    J Invest Dermatol; 2022 Sep; 142(9):2499-2507.e6. PubMed ID: 35189148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
    Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
    Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
    Givant-Horwitz V; Davidson B; Goderstad JM; Nesland JM; Tropé CG; Reich R
    Gynecol Oncol; 2004 May; 93(2):517-23. PubMed ID: 15099972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer.
    Lai AZ; Cory S; Zhao H; Gigoux M; Monast A; Guiot MC; Huang S; Tofigh A; Thompson C; Naujokas M; Marcus VA; Bertos N; Sehat B; Perera RM; Bell ES; Page BD; Gunning PT; Ferri LE; Hallett M; Park M
    Sci Signal; 2014 Apr; 7(322):ra38. PubMed ID: 24757178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia.
    Pigazzi M; Manara E; Beghin A; Baron E; Tregnago C; Basso G
    Clin Cancer Res; 2011 Feb; 17(4):742-52. PubMed ID: 21325296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.